恩替卡韦分散片治疗慢性乙型病毒性肝炎的临床疗效  

Clinical Effect of Entecavir Dispersible Tablets on Treating Patients with Chronic Viral Hepatitis B

作　　者：司进枚 王茜[2] 陈民[1] 徐小国[1] 李青青[1] SI Jinmei;WANG Qian;CHEN Min;XU Xiaoguo;LI Qingqing(Department of Infectious Diseases,Shuyang County People's Hospital,Suqian,Jiangsu 223600,China;Jiangsu Provincial People's Hospital,Nanjing,Jiangsu 210000,China)

机构地区：[1]沭阳县人民医院感染科,江苏宿迁223600 [2]江苏省人民医院,江苏南京210000

出　　处：《大医生》2019年第7期100-101,共2页Doctor

摘　　要：目的分析恩替卡韦分散片治疗慢性乙型病毒性肝炎的临床效果。方法选取沭阳县人民医院感染科2013年3月至2018年3月收治的600例慢性乙型病毒性肝炎患者,采用抽签方式分组,每组300例。观察组实施恩替卡韦分散片治疗,对照组实施常规治疗。比较两组患者的治疗效果。结果两组患者的谷丙转氨酶、白蛋白、总胆红素水平比较,差异有统计学意义(P<0.05)。观察组患者的总有效率明显高于对照组(96.67% vs.66.67%,P<0.05)。结论恩替卡韦分散片治疗慢性乙型病毒性肝炎患者有效。Objective To analyze the clinical effect of entecavir dispersible tablets in the treatment of patients with chronic viral hepatitis b(CHB).Methods 600 patients with CHB admitted to Shuyang County People's Hospital from March 2013 to March 2018 were divided into 2 groups using the lottery method,300 cases per group.The control group received routine medicine treatment,while the observation group received entecavir dispersible tablets.The curative effect of two groups of patients was compared.Results There were significant differences between the two groups in the levels of glutamate transaminase,albumin,and total bilirubin(P<0.05).The total effective rate in the observation group was higher than that in the control group(96.67% vs.66.67%,P<0.05).Conclusion Entecavir dispersible tablets were effective on treating patients with CHB.

关 键 词：恩替卡韦分散片 慢性乙型病毒性肝炎 临床效果 

分 类 号：R51[医药卫生—内科学]